RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

RHUMBLINE ADVISERS's Holding History (CIK: 0001115418)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 507,228 Value ($000) $2,075 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 520,785 Value ($000) $2,541 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 517,255 Value ($000) $2,617 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 359,175 Value ($000) $1,900 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 334,032 Value ($000) $2,258 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 310,468 Value ($000) $2,046 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 281,348 Value ($000) $2,110 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 226,772 Value ($000) $2,261 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 219,067 Value ($000) $2,160 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 221,201 Value ($000) $1,692 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 257,975 Value ($000) $1,927 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 209,878 Value ($000) $1 Avg Close $7.93 Range $6.40 - $9.73
Q4 2022
Shares 205,587 Value ($000) $2 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 204,724 Value ($000) $2,178 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 188,666 Value ($000) $1,536 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 123,892 Value ($000) $887 Avg Close $10.63 Range $5.80 - $18.23
Q4 2021
Shares 119,074 Value ($000) $2,040 Avg Close $18.82 Range $15.25 - $23.86
Q3 2021
Shares 25,284 Value ($000) $582 Avg Close $28.34 Range $17.80 - $42.81
Q2 2021
Shares 20,818 Value ($000) $760 Avg Close $29.60 Range $19.68 - $38.39